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ABSTRACT
Aggressive angiomyxoma (AA) is a rare benign soft tissue tumor usually affecting the female pelvis and perineum. A 
16‑year‑old girl presented on June 23, 2016, with vaginal protrusion of 1‑year duration. Examination revealed protrusion 
through the introitus; it was hyperemic with necrosis. Investigation revealed urinalysis that revealed blood (+), leucocytes (+), 
and others normal; Swab (taken from purulent discharge on the protruded mass) microscopy revealed numerous pus cells; 
and culture yielded no growth. Abdominopelvic ultrasound (USS) showed left‑sided pelvic soft tissue mass with no features 
of metastasis. Other investigations were normal. She had polypectomy with subtotal abdominal hysterectomy. Histology 
revealed benign AA. A rare tumor of the genital tract had been presented with a diagnostic dilemma. However, confirmation 
of diagnosis was easy with histology.
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Introduction
Aggressive angiomyxoma (AA) is a rare benign soft tissue 
tumor affecting the female pelvis and perineum,[1] and was 
first described by Steeper and Rosai in 1983. The tumor is 
benign, nonmetastatic but vascular, infiltrative, and high local 
recurrence, hence the name “aggressive.” Predominantly, 
the tumor occurs in women of reproductive age, but may 
be seen in adolescents and the elderly.[2] Less commonly, it 
may be seen in males involving the inguinoscrotal area and 
perineum with a female: male ratio of 6:1.[3] The tumor has 
estrogen and progesterone receptors and may respond to 
hormone manipulation.[4]
Case Report
This is a case report of a 16-year-old secondary school 
student, who was a single nullipara. Her last menstrual period 
was on June 18, 2016. She presented to the gynecological 
outpatient department as a referred case from a peripheral 
center with vaginal protrusion at menarche a year prior to 
presentation.
It was initially small but increased to about that of an egg. 
There was fullness within the vaginal cavity initially but later 
protruded outside the introitus. There was no protrusion from 
any other part of the body. It was associated with ulceration, 
contact bleeding, foul smelling discharge, and fever. There 
was lower abdominal pain and lower back pain. However, 
there was no inter-menstrual bleeding or heavy menstrual 
flow. There was anorexia and weight loss, but there was no 
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urinary symptoms, hematochezia or constipation, yellowness 
of the eyes, cough, or difficulty in breathing. The history of in 
utero exposure to Diethylstilbestrol could not be ascertained, 
but there was no family history of similar problem and she 
was not sexually active. She had polypectomy at a peripheral 
hospital. The mass recurred to a size larger than it was before 
and a repeat polypectomy was performed about 9 months 
after the first surgery at a different hospital. However, 
histology was not performed. Two weeks after the second 
surgery, the protrusion was noticed to reoccur again, and 
she was then referred to our facility.
Examination findings revealed an ill-looking young woman. 
She was afebrile, not pale, not jaundiced, and cyanosed. She 
had no peripheral lymphadenopathy and no pedal oedema. 
The respiratory, cardiovascular, and abdominal examinations 
were unremarkable. There was an obvious mass protruding 
through the vaginal introitus; it was hyperemic with some 
areas of necrosis and foul smelling discharge. It measured 
about 16 × 15 × 10 centimeters. Further examination was 
impossible due to tenderness and contact bleeding. An 
assessment of a suspected case of sarcoma botryoides was 
made. This is as shown in Figure 1.
The patient and parent were counseled on the condition, 
management, and its implication. She was admitted, and 
investigations results were from urinalysis: the urine was 
clear amber colored; blood (+), leucocytes (+), protein, 
glucose, nitrite, ketone bodies, urobilinogen, and bilirubin 
were negative. Full blood count and differentials revealed 
hematocrit of 35%, platelet count of 235 × 109/L, and 
white blood cell count of 6.9 × 109/L. The differentials 
were neutrophils of 49%, lymphocyte of 26.1%, eosinophils 
of 1.2%, basophils of 0.1%, and monocytes of 7.5%. The 
electrolyte, urea, and creatinine and liver function test 
were also normal. Retroviral screening was nonreactive. 
Swab (taken from purulent discharge on the protruded mass) 
for microscopy revealed numerous pus cells; however, culture 
yielded no growth. Chest X-ray was essentially normal and 
abdominal-pelvic USS showed the liver, spleen, kidneys, and 
urinary bladder. There was a left-sided pelvic soft tissue 
mass with no features of metastasis; the uterus and ovaries 
could not be clearly demonstrated possibly due to distorted 
anatomy. There were no abdominal or pelvic lymph node 
enlargement.
An abdominal-pelvic computer tomography scan was 
requested but was not done due to financial constraint.
She was commenced on antibiotics (intravenous ciprofloxacin 
and metronidazole) for 72 hours and were converted to oral. 
The vulva was cleaned with normal saline twice daily.
They were re-counseled on the findings and the need for 
surgery and its extent which could compromise fertility 
and menstruation. Consent was obtained and she was then 
booked for surgery after her general condition had improved.
She had frozen section of the vaginal mass that revealed a 
polyploidy mass with benign features. She had polypectomy 
with subtotal abdominal hysterectomy on July 05, 2016.
Intra-operative findings revealed a uterine mass that 
destroyed the lower uterine segment and detached the 
cervix from the uterus. There was a small portion of the 
uterine fundus that was held by the fallopian tubes and 
round ligament. The mass pulled the uterus through the 
detached cervical os. The mass was firm and measured 
about 16 × 16 × 12 centimeters. It had no stalk and bled 
to contact. The fallopian tubes and ovaries were normal. 
The estimated blood loss was about 400 milliliters. This is 
as shown in Figure 2.
Figure 1: Vaginal protrusion Figure 2: Extent of the vaginal protrusion
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Through an abdominal incision, the fallopian tubes and the 
round ligament were doubly clamped, cut, and ligated, and 
the remnant of the uterus and attached huge mass were 
delivered vaginally. The proximal margin of the cervix was 
excised to increase tumor free margin while the ovaries were 
preserved.
The post-operative period was uneventful. She was 
maintained on intravenous fluid, antibiotics, and analgesics 
for 48 hours. She was changed to oral medication for 5 days 
and her post-operative packed cell volume on the second day 
was 32%. They were counseled on the extent of the surgery 
and stitches were removed on the seventh post-operative day. 
She was discharged home thereafter in satisfactory condition.
She reported to the gynecological clinic after 2 weeks with a 
histology report that revealed a mesenchymal neoplasm that 
is poorly circumscribed, composed of spindle shaped cells 
widely sparse from each other in a myxoid stroma, within 
which are numerous clusters of small to moderately sized 
vascular channels suggestive of a benign AA.
They were reassured and counseled on the findings and 
prognosis, in addition to fertility option of in vitro fertilization 
and surrogacy. The possibility of adoption and fostering was 
also discussed when ready for childbearing. She has been 
on follow-up at the gynecological clinic with no features 
of recurrence. She will be followed up for life due to high 
chance of recurrence.
Discussion
The pathogenesis of AA is not clearly known; however, 
genetic alterations on the 12q chromosome region have 
been implicated with aberrant expression of high mobility 
group A (HMGA) protein associated with DNA transcription.[5] 
It may arise from special mesenchymal cells of the pelvis and 
perineum or from perivascular progenitor cells with various 
degrees of myofibroblastic features.[6] It is present in the 
fourth decade in women of reproductive age,[2] but may be 
seen in adolescents, as in the case presented, the patient 
was 16 years old. It is usually misdiagnosed because it is 
rare. It was also seen as a uterine polyp in a patient from 
Czech Republic.[7] The clinical presentation is similar to many 
other conditions such as fibroid polyp, pelvic organ prolapse, 
neurofibromatosis, and genital cancers. This could explain 
why the diagnosis was repeatedly missed in this patient.
Diagnosis is mainly histological. Grossly, it is unencapsulated 
and may blend imperceptibly with surrounding soft tissue.[8] 
It has variable sizes with rubbery consistency and glistening, 
gelatinous cut surface. The tumor is sparsely cellular 
composed of pale eosinophilic stroma embedded with 
numerous haphazardly arranged blood vessels in a myxoid 
background.[9] Soft tissue infiltration is common. The tumor is 
diffusely immunopositive for vimentin and desmin.[8] They are 
also estrogen and progesterone receptor positive. The diagnosis 
in this patient was confirmed by the histological findings of 
the mesenchymal neoplasm that was poorly circumscribed, 
composed of spindle shaped cells widely sparse from each 
other in a myxoid stroma, within which are numerous clusters 
of small to moderately sized vascular channels.
Other supportive diagnostic methods include USS, magnetic 
resonant imaging (MRI), and computed tomography (CT) 
scanning. On USS, the mass usually appear hypoechoic 
while MRI and CT delineate the extent of the tumor. On 
CT, the tumor has attenuation less than that of muscle or it 
may be mainly cystic with solid components.[9] This tumor 
also exhibits avid and heterogeneous enhancement after 
administration of contrast. In the case presented, USS showed 
left-sided pelvic soft tissue mass; however, there were no 
features suggestive of metastasis. CT scan or MRI could not 
be done because of financial constraint of the patient.
The primary treatment of AA is a wide local excision, although 
achieving negative resection margin is difficult due to the 
absence of capsule and its infiltrative nature.[10] Smaller and 
superficial tumors of the vulva and vagina may be removed 
with less difficulty but larger deep-seated tumors of the pelvis 
may necessitate extensive procedure with partial or complete 
resection of some pelvic organs.[10] In this patient, a greater 
part of the uterus had been destroyed with detachment of 
the cervix from the uterine corpus. Therefore, polypectomy 
with subtotal hysterectomy was performed with satisfactory 
outcome. The tumor has potential for local aggression and 
recurrence after excision. This may explain why she had two 
previous excisions in less than a year before being referred 
to us.
Other treatment modalities include radiotherapy and 
chemotherapy with poor results. Radiation therapy with 
tumor embolization can be used to decrease recurrence 
where tumor is large.[10] In this index, patient adjuvant therapy 
was not considered because there was significant free tumor 
margin on histology.
Conclusion
AA is a rare tumor of which primary uterine corpus type 
is even rarer and often misdiagnosed. It is mainly seen in 
women of reproductive age especially in the fourth decade 
but may also be seen in younger age group. Wide local 
excision is the treatment of choice in superficial mass; deeper 
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tumors may require partial or complete resection of pelvic 
organ. There is need for high index of suspicion when dealing 
with genital swellings.
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